PTGX — Protagonist Therapeutics, Inc

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1377121 ·
Last close
$124.67
Market Cap
$8.07B
52W High
$160.81
52W Low
$77.00
ADV30
673,093
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 274,410,000 273,310,000 218,332,000 220,015,000 1,146,551,000 498,298,000 61,641,000
Jun 2026 213,475,000 — 158,766,000 162,849,000 885,544,000 420,078,000 44,001,000
Mar 2026 56,368,000 — -3,648,000 3,783,000 697,459,000 193,712,000 41,986,000
Dec 2025 7,437,000 — -50,355,000 -44,384,000 668,188,000 128,390,000 53,481,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$131,197,000
Investing CF
$78,722,000
Financing CF
$41,613,000
CapEx
$-615,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$1.03
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-304,039,000
Inventory
—
Receivables
$19,642,000
ST Investments
$362,498,000
EBIT TTM
$58,342,000
Pretax Income TTM
$84,338,000
Interest Exp TTM
—
Analysts
14

Yahoo Snapshot (yfinance, live)

Total Revenue
$551,689,984
EBITDA
$324,662,016
Free Cash Flow
$96,145,752
Enterprise Value
$7,770,721,792
Total Cash
$782,576,000
Total Debt
$9,216,000
Shares Out
64,708,285
Trailing EPS
$4.73
Book Value
$13.01
ROE
11.0%
ROA
4.5%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 46,016,000 -158,127,000 -130,149,000 668,188,000 53,481,000 614,707,000 57,671,000
Dec 2024 434,433,000 252,843,000 275,188,000 744,725,000 69,430,000 675,295,000 184,152,000
Dec 2023 60,000,000 -93,652,000 -78,955,000 357,951,000 21,274,000 336,677,000 -70,236,000
Dec 2022 26,581,000 -131,373,000 -127,393,000 247,928,000 32,320,000 215,608,000 -108,137,000

TTM Snapshot

Revenues TTM
$281,992,000
NetIncome TTM
$82,909,000
OpCashFlow TTM
—
Assets (Latest)
$885,544,000
Forward EPS
$0.23

Max Pain — expiry 2027-01-15

max pain strike: $105.00 · spot: $127.16 · call oi: 59 · put oi: 1,533
Expected Move to 2027-01-15: ±$19.60 (15.41%) — implied range $107.56 – $146.76 · ATM straddle on $125.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
RYTM RHYTHM PHARMACEUTICALS, INC. $8.08B $116.61 —
CORT CORCEPT THERAPEUTICS INC $7.67B $70.07 —
ALKS Alkermes plc. $7.64B $45.45 —
PRAX Praxis Precision Medicines, Inc. $8.53B $305.06 —
SMMT Summit Therapeutics Inc. $8.53B $10.67 —

News headlines (Yahoo Finance, 1h cache)

How Much Upside is Left in Protagonist Therapeutics (PTGX)? Wall Street Analysts Think 37.6%
2026-11-16 13:55 · Yahoo
Protagonist Therapeutics (PTGX) Stock Looks Priced At A Premium As Its 7x Three Year Run Continues
2026-11-06 17:15 · Yahoo
Earnings Beat Might Change The Case For Investing In Protagonist Therapeutics Stock
2026-11-06 12:17 · Yahoo
Protagonist Therapeutics (PTGX) Swung To Profit, Is It A Bargain Or Fully Priced?
2026-11-06 11:13 · Yahoo
Protagonist Therapeutics (PTGX) Q3 Earnings and Revenues Surpass Estimates
2026-11-05 21:45 · Yahoo
Protagonist Therapeutics: Q3 Earnings Snapshot
2026-11-05 21:22 · Yahoo
Protagonist Reports Third Quarter 2026 Financial Results and Provides Corporate Update
2026-11-05 21:05 · Yahoo
Protagonist Therapeutics (PTGX) to Report Q3 Results: Wall Street Expects Earnings Growth
2026-10-29 13:00 · Yahoo
Wall Street Analysts See a 25.34% Upside in Protagonist Therapeutics (PTGX): Can the Stock Really Move This High?
2026-10-28 12:55 · Yahoo
Protagonist Therapeutics to Participate in Four Investment Bank Conferences in November 2026
2026-10-27 11:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.